Certified by Founder Lodge
Actym Therapeutics, Inc.
United States - Berkeley, CA
START UP
1 Disclosed Funding Rounds $59,500,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 20 ,2023 | Series A | $59,500,000 |
Illumina Ventures
Boehringer Ingelheim
Panacea Venture
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Transition Metal Solutions | $6,000,000 | (Jan 20, 2026)
Tulip Interfaces | $120,000,000 | (Jan 20, 2026)
Fanvue | $22,000,000 | (Jan 20, 2026)
Gutology | $2,418,300 | (Jan 20, 2026)
Fleetzero | $43,000,000 | (Jan 20, 2026)
